Extracellular Vesicles for Childhood Cancer Liquid Biopsy
Open Access
Abstract
Liquid biopsy involves the utilization of minimally invasive or noninvasive techniques to detect biomarkers in biofluids for disease diagnosis, monitoring, or guiding treatments. This approach is promising for the early diagnosis of childhood cancer, especially for brain tumors, where tissue biopsies are more challenging and cause late detection. Extracellular vesicles offer several characteristics that make them ideal resources for childhood cancer liquid biopsy. Extracellular vesicles are nanosized particles, primarily secreted by all cell types into body fluids such as blood and urine, and contain molecular cargos, i.e., lipids, proteins, and nucleic acids of original cells. Notably, the lipid bilayer-enclosed structure of extracellular vesicles protects their cargos from enzymatic degradation in the extracellular milieu. Proteins and nucleic acids of extracellular vesicles represent genetic alterations and molecular profiles of childhood cancer, thus serving as promising resources for precision medicine in cancer diagnosis, treatment monitoring, and prognosis prediction. This review evaluates the recent progress of extracellular vesicles as a liquid biopsy platform for various types of childhood cancer, discusses the mechanistic roles of molecular cargos in carcinogenesis and metastasis, and provides perspectives on extracellular vesicle-guided therapeutic intervention. Extracellular vesicle-based liquid biopsy for childhood cancer may ultimately contribute to improving patient outcomes.Keywords
Funding Information
- Genomic Thailand Project of the Health Systems Research Institute (HSRI64-130)
- Ramathibodi Foundation (HSRI64-130)
This publication has 133 references indexed in Scilit:
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Plasma small‐extracellular vesicles enriched in miR‐122‐5p promote disease aggressiveness in pediatric anaplastic large‐cell lymphomaCancer Communications, 2023
- Anti‐SARS‐CoV‐2 effect of extracellular vesicles released from mesenchymal stem cellsJournal of Extracellular Vesicles, 2022
- Clinical significance of circulating tumor cells and cell‐free DNA in pediatric rhabdomyosarcomaMolecular Oncology, 2022
- Assessment of somatic mutations in urine and plasma of Wilms tumor patientsCancer Medicine, 2020
- Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosisInternational Journal of Cancer, 2018
- Proteomic Analysis of Neuroblastoma‐Derived Exosomes: New Insights into a Metastatic SignatureProteomics, 2017
- Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based studyPediatric Surgery International, 2016
- Neuroblastoma cell detection by reverse transcriptase‐polymerase chain reaction (RT‐PCR) for tyrosine hydroxylase mRNAInternational Journal of Cancer, 1994
- Serial immunocytologic analysis of blood for tumor cells in two patients with neuroblastomaCancer, 1991